L’anticoagulant unique anti-(32-GPI et la perte fœtale

dc.contributor.advisorM. NAZIH
dc.contributor.authorNajwa Modni
dc.date.accessioned2023-09-15T13:41:16Z
dc.date.accessioned2026-01-22T13:33:13Z
dc.date.available2023-09-15T13:41:16Z
dc.date.issued2018
dc.description.collaboratorA. MASRAR
dc.description.collaboratorS. BENKIRANE
dc.description.collaboratorL. DAMI
dc.identifier.urihttps://toubkal.imist.ma/handle/123456789/18993
dc.identifier.urihttps://doi.org/10.83129/toubkal-6718
dc.language.isofr
dc.publisherUniversité Mohammed 5 de Rabat, Faculté de Médecine et de Pharmacie, Rabatfr_FR
dc.subjectAnticoagulant uniquefr_FR
dc.subjectanti-(32-GPIfr_FR
dc.subjectthrombosefr_FR
dc.subject.otherSciences médicales
dc.subject.specificHématologie
dc.titleL’anticoagulant unique anti-(32-GPI et la perte fœtalefr_FR

Files